Soligenix is interested in identifying new partnership and merger opportunities for its existing products as well as new in-licensing candidates in the areas of gastrointestinal, supportive cancer care, and biodefense. We can provide attractive compensation for any leads that result in new licenses at Soligenix or a new partnership for one of our existing products.

Please direct Business Development inquiries to:

Karen Krumeich
Chief Financial Officer
Soligenix, Inc.
29 Emmons Drive – Suite C-10
Princeton, NJ 08540
Phone: (609) 538-8200
Fax: (609) 452-6467
E-mail: kkrumeich@nullsoligenix.com

For more information: